Additionally, we constructed TF-mRNA regulatory and ceRNA networks of these biomarkers to predict potential drugs, which can provide potential targets for clinical diagnosis of T2DM and a theoretical basis for further understanding of the driving mechanism of T2DM. This evidence concerns the gene TF and type 2 diabetes mellitus.